Vivek Ramaswamy: Developing Drugs For Neglected Diseases - The Forbes Interview
THE FORBES INTERVIEW

Vivek Ramaswamy: Developing Drugs For Neglected Diseases


Google+
Vivek Ramaswamy: Developing Drugs For Neglected Diseases
Founder and CEO of Roivant Sciences, 31-year-old Vivek Ramaswamy, goes deep into the workings of the pharmaceutical industry. He explores questions including: Why take on Alzheimers when other big pharmaceuticals aren't? Why have there been so few changes in drug development for women's health? And why he's willing to take the financial risk of investing in drug research that fails. 

Comments
You must be a premium member to leave a comment.